We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$16.3B
AUM Growth
-$40.2M
(-0.25%)
Cap. Flow
-$420M
Cap. Flow % of AUM
Cap. Flow %
-2.59%
Top 10 Holdings %
Top 10 Hldgs %
42.17%
Holding
1,545
New
54
Increased
211
Reduced
408
Closed
84
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$141M |
| 2 |
Chubb
CB
|
+$56.9M |
| 3 |
Apple
AAPL
|
+$39.9M |
| 4 |
Perrigo
PRGO
|
+$39.1M |
| 5 |
Service Corp International
SCI
|
+$30.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$150M |
| 2 |
CHUBB CORPORATION
CB
|
+$110M |
| 3 |
American International
AIG
|
+$103M |
| 4 |
AGN
Allergan plc
AGN
|
+$96.4M |
| 5 |
CVS Health
CVS
|
+$45.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.84% |
| 2 | Healthcare | 15.27% |
| 3 | Industrials | 9.13% |
| 4 | Miscellaneous | 8.1% |
| 5 | Technology | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.16T
| $3.17B | 19.49% |
14,845
-73
| -0.5% | -$14.6M |
2013 Q2
11 quarters
|
|
2
Brookfield
BN
$84.8B
| $610M | 3.75% |
49,940,816
+96,823
| +0.2% | +$1.04M |
2013 Q2
11 quarters
|
|
3
Microsoft
MSFT
$3.89T
| $434M | 2.67% |
7,865,133
-345,266
| -4% | -$18.1M |
2013 Q2
11 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.16T
| $381M | 2.34% |
2,685,899
+50,790
| +2% | +$6.73M |
2013 Q2
11 quarters
|
|
|
5
CVS Health
CVS
$120B
| $319M | 1.96% |
3,070,825
-467,303
| -13% | -$45.4M |
2013 Q2
11 quarters
|
|
6
AB InBev
BUD
$166B
| $312M | 1.92% |
2,499,020
+9,778
| +0.4% | +$1.16M |
2013 Q2
11 quarters
|
|
|
7
Apple
AAPL
$5.07T
| $295M | 1.81% |
10,813,380
+1,601,892
| +17% | +$39.9M |
2013 Q2
11 quarters
|
|
8
Johnson & Johnson
JNJ
$635B
| $293M | 1.8% |
2,705,568
-119,024
| -4% | -$12.3M |
2013 Q2
11 quarters
|
|
9
Zimmer Biomet
ZBH
$18.8B
| $275M | 1.69% |
2,656,121
+116,319
| +5% | +$11.3M |
2013 Q2
11 quarters
|
|
|
10
Perrigo
PRGO
$2.21B
| $264M | 1.62% |
2,061,362
+285,766
| +16% | +$39.1M |
2014 Q1
8 quarters
|
|
11
Wells Fargo
WFC
$247B
| $250M | 1.54% |
5,169,416
-550,510
| -10% | -$27M |
2013 Q2
11 quarters
|
|
|
12
Pfizer
PFE
$171B
| $247M | 1.52% |
8,785,789
+4,923,294
| +127% | +$141M |
2013 Q2
11 quarters
|
|
13
Danaher
DHR
$162B
| $246M | 1.52% |
3,862,523
+290,677
| +8% | +$17.3M |
2013 Q2
11 quarters
|
|
14
Honeywell
HON
$70.1B
| $229M | 1.41% |
2,278,501
-49,047
| -2% | -$4.6M |
2013 Q2
11 quarters
|
|
15
Aramark
ARMK
$13.9B
| $219M | 1.35% |
9,144,896
-258,498
| -3% | -$5.93M |
2014 Q2
7 quarters
|
|
16
H&R Block
HRB
$6.09B
| $206M | 1.27% |
7,790,366
+71,701
| +0.9% | +$2.25M |
2013 Q2
11 quarters
|
|
17
Comcast
CMCSA
$80.6B
| $199M | 1.22% |
6,506,808
+728,916
| +13% | +$20.9M |
2013 Q2
11 quarters
|
|
18
Oracle
ORCL
$382B
| $185M | 1.14% |
4,531,843
-250,209
| -5% | -$9.26M |
2013 Q2
11 quarters
|
|
19
Philip Morris
PM
$311B
| $173M | 1.06% |
1,763,108
-8,048
| -0.5% | -$738K |
2013 Q2
11 quarters
|
|
|
DISCK
20
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $163M | 1% |
6,021,347
-477,390
| -7% | -$12.4M |
2013 Q2
11 quarters
|
|
21
Gilead Sciences
GILD
$193B
| $154M | 0.94% |
1,671,808
+127,631
| +8% | +$11.5M |
2013 Q2
11 quarters
|
|
|
22
American International
AIG
$42.5B
| $140M | 0.86% |
2,597,073
-1,903,447
| -42% | -$103M |
2013 Q2
11 quarters
|
|
23
Accenture
ACN
$153B
| $137M | 0.84% |
1,183,071
-9,180
| -0.8% | -$943K |
2013 Q2
11 quarters
|
|
|
JAH
24
DELISTED
JARDEN CORPORATION
JAH
| $130M | 0.8% |
2,198,721
-14,119
| -0.6% | -$755K |
2013 Q2
11 quarters
|
|
25
3M
MMM
$89.5B
| $127M | 0.78% |
910,777
-3,463
| -0.4% | -$445K |
2013 Q2
11 quarters
|
|
Similar funds
First Manhattan's Q1 2016 Portfolio in Review
As of Q1 2016, First Manhattan held 1,545 positions worth $16.3B, down 0.25% from $16.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
First Manhattan's Q1 2016 filing shows 54 new, 211 increased, 408 reduced and 84 closed positions. Its largest new stake was GCP Applied Technologies Inc.: 600,612 shares worth $12M. The largest sale was RTX Corp, an estimated $150M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q1 2016 buy was GCP Applied Technologies Inc.: 600,612 shares worth $12M.
- First Manhattan added most to Pfizer in Q1 2016, an estimated $141M increase.
- First Manhattan's biggest Q1 2016 reduction was RTX Corp, cutting an estimated $150M.
- First Manhattan fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $110M.
- First Manhattan's ten largest holdings make up 42% of its $16.3B portfolio in Q1 2016.
- First Manhattan opened 54 new positions and closed 84 in Q1 2016.
- First Manhattan's portfolio value fell 0.25% quarter-over-quarter to $16.3B.
Based on First Manhattan's 13F filing for Q1 2016, filed 22 Apr 2016.